Your browser doesn't support javascript.
loading
Therapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathway.
Nakamuta, M; Fujino, T; Yada, R; Yasutake, K; Yoshimoto, T; Harada, N; Yada, M; Higuchi, N; Kato, M; Kohjima, M; Taketomi, A; Maehara, Y; Nishinakagawa, T; Machida, K; Matsunaga, K; Nakashima, M; Kotoh, K; Enjoji, M.
Affiliation
  • Nakamuta M; Department of Gastroenterology, Kyushu Medical Center, National Hospital Organization, Japan.
Int J Clin Pharmacol Ther ; 48(1): 22-8, 2010 Jan.
Article in En | MEDLINE | ID: mdl-20040336
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phospholipids / Bezafibrate / Jaundice, Obstructive / Hypolipidemic Agents Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Clin Pharmacol Ther Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2010 Document type: Article Affiliation country:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phospholipids / Bezafibrate / Jaundice, Obstructive / Hypolipidemic Agents Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Clin Pharmacol Ther Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2010 Document type: Article Affiliation country: